Study reveals new target for treating sleep apnea

Article linking hepatitis B vaccines to autism is retracted by the Journal of Toxicology and Environmental Health because of critical methodological flaws

Podcast with some of the authors from The Lancet Special issue in Neurology: advances and challenges in the field

Genetically engineered hookworms can now secrete human therapeutic antibodies directly into their host's circulation, offering a potential single-dose, years-long drug delivery platform

Researchers have identified RNA biomarkers, known as “SECmeres”, that could provide a simple blood test for earlier Alzheimer's diagnosis

New Benchmark Evaluates AI for Everyday Patient Care

Study: Patients With Hypermobility Disorders Experience Less Pain, Consume Fewer Opioids Following Medical Cannabis Treatment

One or two psilocybin doses still lifting depression a year on

Triple-action diabetes jab shown to reduce blood sugar and body weight

Elecoglipron, an oral GLP-1 drug taken daily, demonstrated clinically meaningful weight reductions in adults with obesity or overweight, in a new randomised, placebo-controlled clinical trial.

An AI-based spatial analysis of the tumor microenvironment has identified immune cell markers that can accurately predict which intermediate-risk breast cancer patients can safely forgo chemotherapy…

Case report: transient return of speech and continence in advanced dementia patient after 5g psilocybin mushrooms

Clinical Trial: Cannabis Oil Provides “Clinically Meaningful” Improvements in Fibromyalgia Symptoms

Researchers have successfully mimicked the electrical behavior of biological heart muscle cells using a new type of conductive plastic, paving the way for revolutionary bioelectronics and advanced treatments for cardiac diseases.

Researchers develop a real-time, bedside brain monitor that continuously analyzes cerebrospinal fluid for biomarkers

RNA Biomarkers Could Offer a Simple Blood Test for Earlier Alzheimer’s Diagnosis

AI-designed universal coronavirus vaccine passes first human trial

World-first: therapy to make cells young again trialled in a person

Semaglutide, a GLP-1 weight loss drug, slowed biological aging across multiple epigenetic clocks in a randomized, double-blind, placebo-controlled clinical trial in patients with HIV, suggesting that the drug may influence aging-related biology across multiple body systems.

Microbubbles in Medicine

American Medical Association (AMA) Adopts Policy Pushing Back on AI Creep in Medicine

This sticky substance could be a rare example of Neanderthal medicine

Magnetic Reprogramming of Macrophages Stimulates Phagocytosis of Breast Cancer Cells via a TRPC1‐STING Inflammatory Axis - Sukumar - 2026 - Smart Medicine - Wiley Online Library

IP28-23 POST-SSRI SEXUAL DYSFUNCTION: A 15 YEAR REVIEW OF SEXUAL SYMPTOMS AND BIOLOGIC PATHOPHYSIOLOGIES | Journal of Urology

Abortion bans in 14 states lead to 9.2% increase in pregnancy-associated deaths of women.

Climate crisis is accelerating antibiotic resistance across world

US state-level abortion bans are associated with a reduction in evidence-based medical care for miscarriage management

Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection | New England Journal of Medicine

Frontiers | DXM, CYP2D6-inhibiting antidepressants, piracetam, and glutamine: proposing a ketamine-class antidepressant regimen with existing drugs

Magic mushrooms could be effective treatment for cocaine addiction, study shows

More →